# A Real World Study of the Effect of Early PEG-rhGH Therapy on Cognitive Development of SGA Infants

> **NCT05144035** · PHASE4 · RECRUITING · sponsor: **Tongji Hospital** · enrollment: 138 (estimated)

## Conditions studied

- Small for Gestational Age Infant
- Growth Hormone Treatment
- Cognitive Developmental Disorder

## Interventions

- **DRUG:** PEG-rhGH

## Key facts

- **NCT ID:** NCT05144035
- **Lead sponsor:** Tongji Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-04-06
- **Primary completion:** 2025-12-31
- **Final completion:** 2026-06-30
- **Target enrollment:** 138 (ESTIMATED)
- **Last updated:** 2023-04-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05144035

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05144035, "A Real World Study of the Effect of Early PEG-rhGH Therapy on Cognitive Development of SGA Infants". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05144035. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*